晨光生物2025年度归母净利润3.64亿元，增长286.65%

Core Viewpoint - Morning Light Bio (300138.SZ) reported significant growth in its 2025 annual performance, with substantial increases in revenue and profits across various business segments [1] Financial Performance - The company achieved a total revenue of 6.564 billion yuan, with operating profit and total profit increasing by 313.92% and 311.82% year-on-year, respectively [1] - The net profit attributable to shareholders reached 364 million yuan, reflecting a year-on-year growth of 286.65% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses, as well as basic earnings per share, saw increases of 595.83% and 320.30% year-on-year, respectively [1] Business Segments - The plant extraction business experienced growth in both revenue and gross profit year-on-year [1] - The cottonseed business faced a decrease in trading volume, leading to a decline in revenue; however, with market recovery, product profit margins improved, resulting in a turnaround from loss to profit, which contributed to the overall performance growth of the company [1]